TY - JOUR AU - Macbeth, F. R. AU - Wheldon, T. E. AU - Girling, D. J. AU - Stephens, R. J. AU - Machin, D. AU - Bleehen, N. M. PY - 1996 DA - 1996// TI - Radiation myelopathy: estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer: the Medical Research Council Lung Cancer Working Party JO - Clin Oncol (R Coll Radiol) VL - 8 UR - https://doi.org/10.1016/S0936-6555(96)80042-2 DO - 10.1016/S0936-6555(96)80042-2 ID - Macbeth1996 ER - TY - JOUR AU - Kris, M. G. AU - Natale, R. B. AU - Herbst, R. S. AU - Lynch, T. J. AU - Prager, D. AU - Belani, C. P. PY - 2003 DA - 2003// TI - Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial JO - JAMA VL - 290 UR - https://doi.org/10.1001/jama.290.16.2149 DO - 10.1001/jama.290.16.2149 ID - Kris2003 ER - TY - JOUR AU - Jackman, D. M. AU - Holmes, A. J. AU - Lindeman, N. AU - Wen, P. Y. AU - Kesari, S. AU - Borras, A. M. PY - 2006 DA - 2006// TI - Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2006.06.6126 DO - 10.1200/JCO.2006.06.6126 ID - Jackman2006 ER - TY - JOUR AU - Tanaka, T. AU - Munshi, A. AU - Brooks, C. AU - Liu, J. AU - Hobbs, M. L. AU - Meyn, R. E. PY - 2008 DA - 2008// TI - Gefitinib radiosensitizes non-small cell lung cancer cells by suppressing cellular DNA repair capacity JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-07-1606 DO - 10.1158/1078-0432.CCR-07-1606 ID - Tanaka2008 ER - TY - JOUR AU - Ready, N. AU - Jänne, P. A. AU - Bogart, J. AU - Dipetrillo, T. AU - Garst, J. AU - Graziano, S. PY - 2010 DA - 2010// TI - Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trial JO - J Thorac Oncol VL - 5 UR - https://doi.org/10.1097/JTO.0b013e3181eba657 DO - 10.1097/JTO.0b013e3181eba657 ID - Ready2010 ER - TY - JOUR AU - Kang, K. B. AU - Zhu, C. AU - Wong, Y. L. AU - Gao, Q. AU - Ty, A. AU - Wong, M. C. PY - 2012 DA - 2012// TI - Gefitinib radiosensitizes stem-like glioma cells: inhibition of epidermal growth factor receptor-Akt-DNA-PK signaling, accompanied by inhibition of DNA double-strand break repair JO - Int J Radiat Oncol Biol Phys VL - 83 UR - https://doi.org/10.1016/j.ijrobp.2011.11.037 DO - 10.1016/j.ijrobp.2011.11.037 ID - Kang2012 ER - TY - JOUR AU - Park, S. -. Y. AU - Kim, Y. M. AU - Pyo, H. PY - 2010 DA - 2010// TI - Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutated JO - Mol Cancer VL - 9 UR - https://doi.org/10.1186/1476-4598-9-222 DO - 10.1186/1476-4598-9-222 ID - Park2010 ER - TY - JOUR AU - Chen, F. -. H. AU - Fu, S. -. Y. AU - Yang, Y. -. C. AU - Wang, C. -. C. AU - Chiang, C. -. S. AU - Hong, J. -. H. PY - 2013 DA - 2013// TI - Combination of vessel-targeting agents and fractionated radiation therapy: the role of the SDF-1/CXCR4 pathway JO - Int J Radiat Oncol Biol Phys VL - 86 UR - https://doi.org/10.1016/j.ijrobp.2013.02.036 DO - 10.1016/j.ijrobp.2013.02.036 ID - Chen2013 ER - TY - JOUR AU - Stinchcombe, T. E. AU - Morris, D. E. AU - Lee, C. B. AU - Moore, D. T. AU - Hayes, D. N. AU - Halle, J. S. PY - 2008 DA - 2008// TI - Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small cell lung cancer JO - J Thorac Oncol VL - 3 UR - https://doi.org/10.1097/JTO.0b013e3181653cf4 DO - 10.1097/JTO.0b013e3181653cf4 ID - Stinchcombe2008 ER - TY - JOUR AU - Supe, S. S. AU - Ganesh, K. M. AU - Naveen, T. AU - Jacob, S. AU - Sankar, B. N. PY - 2006 DA - 2006// TI - Spinal cord response to altered fractionation and re-irradiation: radiobiological considerations and role of bioeffect models JO - J Cancer Res Ther VL - 2 UR - https://doi.org/10.4103/0973-1482.27597 DO - 10.4103/0973-1482.27597 ID - Supe2006 ER - TY - JOUR AU - Higashida, T. AU - Colen, C. B. AU - Guthikonda, M. PY - 2010 DA - 2010// TI - Diagnostic and therapeutic strategy for confounding radiation myelitis JO - Clin Neurol Neurosurg VL - 112 UR - https://doi.org/10.1016/j.clineuro.2009.12.009 DO - 10.1016/j.clineuro.2009.12.009 ID - Higashida2010 ER - TY - JOUR AU - Koehler, P. J. AU - Verbiest, H. AU - Jager, J. AU - Vecht, C. J. PY - 1996 DA - 1996// TI - Delayed radiation myelopathy: serial MR-imaging and pathology JO - Clin Neurol Neurosurg VL - 98 UR - https://doi.org/10.1016/0303-8467(96)00017-0 DO - 10.1016/0303-8467(96)00017-0 ID - Koehler1996 ER - TY - JOUR AU - Schultheiss, T. E. PY - 2008 DA - 2008// TI - The radiation dose-response of the human spinal cord JO - Int J Radiat Oncol Biol Phys VL - 71 UR - https://doi.org/10.1016/j.ijrobp.2007.11.075 DO - 10.1016/j.ijrobp.2007.11.075 ID - Schultheiss2008 ER - TY - JOUR AU - Adamus-Gorka, M. AU - Brahme, A. AU - Mavroidis, P. AU - Lind, B. K. PY - 2008 DA - 2008// TI - Variation in radiation sensitivity and repair kinetics in different parts of the spinal cord JO - Acta Oncol VL - 47 UR - https://doi.org/10.1080/02841860701864668 DO - 10.1080/02841860701864668 ID - Adamus-Gorka2008 ER - TY - JOUR AU - Marks, L. B. AU - Yorke, E. D. AU - Jackson, A. AU - Haken, R. K. AU - Constine, L. S. AU - Eisbruch, A. PY - 2010 DA - 2010// TI - Use of normal tissue complication probability models in the clinic JO - Int J Radiat Oncol Biol Phys VL - 76 UR - https://doi.org/10.1016/j.ijrobp.2009.07.1754 DO - 10.1016/j.ijrobp.2009.07.1754 ID - Marks2010 ER - TY - JOUR AU - Dunst, J. AU - Gebhart, E. PY - 1995 DA - 1995// TI - Unexpected tumor response, radiation myelitis and increased in vitro-radio-sensitivity of lymphocytes in a patient with non-small lung cancer JO - Radiother Oncol VL - 36 UR - https://doi.org/10.1016/0167-8140(95)01592-5 DO - 10.1016/0167-8140(95)01592-5 ID - Dunst1995 ER - TY - JOUR AU - Mahta, A. AU - Borys, E. AU - Kanakamedala, M. R. AU - Kesari, S. PY - 2012 DA - 2012// TI - Radiation induced myelopathy in a patient with tongue cancer: a case report JO - Acta Oncol VL - 51 UR - https://doi.org/10.3109/0284186X.2011.631578 DO - 10.3109/0284186X.2011.631578 ID - Mahta2012 ER - TY - JOUR AU - Okada, S. AU - Okeda, R. PY - 2001 DA - 2001// TI - Pathology of radiation myelopathy JO - Neuropathology VL - 21 UR - https://doi.org/10.1046/j.1440-1789.2001.00408.x DO - 10.1046/j.1440-1789.2001.00408.x ID - Okada2001 ER - TY - JOUR AU - Ceresoli, G. L. AU - Cappuzzo, F. AU - Gregorc, V. AU - Bartolini, S. AU - Crinò, L. AU - Villa, E. PY - 2004 DA - 2004// TI - Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial JO - Ann Oncol VL - 15 UR - https://doi.org/10.1093/annonc/mdh276 DO - 10.1093/annonc/mdh276 ID - Ceresoli2004 ER - TY - JOUR AU - Iivanainen, E. AU - Lauttia, S. AU - Zhang, N. AU - Tvorogov, D. AU - Kulmala, J. AU - Grenman, R. PY - 2009 DA - 2009// TI - The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels JO - Microvasc Res VL - 78 UR - https://doi.org/10.1016/j.mvr.2009.06.010 DO - 10.1016/j.mvr.2009.06.010 ID - Iivanainen2009 ER - TY - JOUR AU - Stewart, J. S. AU - Cohen, E. E. AU - Licitra, L. AU - Herpen, C. M. AU - Khorprasert, C. AU - Soulieres, D. PY - 2009 DA - 2009// TI - Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected] JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.17.0530 DO - 10.1200/JCO.2008.17.0530 ID - Stewart2009 ER - TY - JOUR AU - Geyer, J. R. AU - Stewart, C. F. AU - Kocak, M. AU - Broniscer, A. AU - Phillips, P. AU - Douglas, J. G. PY - 2010 DA - 2010// TI - A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas JO - Eur J Cancer VL - 46 UR - https://doi.org/10.1016/j.ejca.2010.07.005 DO - 10.1016/j.ejca.2010.07.005 ID - Geyer2010 ER -